Medtronic Dividends and Buybacks
Dividend criteria checks 5/6
Medtronic is a dividend paying company with a current yield of 3.03% that is well covered by earnings.
Key information
3.0%
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 3.3% |
| Future Dividend Yield | 3.3% |
| Dividend Growth | 7.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 77% |
Recent dividend and buyback updates
Recent updates
Medtronic: A Revitalized Dividend Aristocrat To Buy Now
Oct 26Medtronic's (NYSE:MDT) Solid Earnings Are Supported By Other Strong Factors
Sep 03
Medtronic's (NYSE:MDT) Returns On Capital Are Heading Higher
Jul 07
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jun 16Medtronic (NYSE:MDT) Will Pay A Larger Dividend Than Last Year At $0.71
May 30Medtronic: One Of The Best Times To Buy
Apr 21Is Now An Opportune Moment To Examine Medtronic plc (NYSE:MDT)?
Apr 14Medtronic: A Great Business, But With Low Growth
Mar 27Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
Mar 20Medtronic Stock: A Compelling Buy for Value and Income Investors as Robotics, Innovation Catalysts Ignite Upside to $105+
Strengths and Competitive Advantages:Diverse Product Portfolio: Medtronic operates across four key segments—Cardiovascular, Medical-Surgical, Neuroscience, and Diabetes—providing revenue stability andMedtronic (NYSE:MDT) Has More To Do To Multiply In Value Going Forward
Feb 17Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
Feb 15Medtronic: Undervalued But Underperforming - Why Innovation Isn't Enough To Lift The Stock
Feb 07We Think Medtronic (NYSE:MDT) Can Stay On Top Of Its Debt
Jan 20Medtronic: A Dividend Aristocrat That's Poised To Pop
Jan 06Investors Appear Satisfied With Medtronic plc's (NYSE:MDT) Prospects
Jan 06Medtronic Stock Is Still A Great "Buy"
Dec 26Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Dec 03Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Nov 19Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns
Nov 08Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Oct 31Medtronic: Undervalued Dividend Aristocrat With High Margins
Oct 10Medtronic: An Undervalued Stock With Durable Competitive Advantages
Sep 16Medtronic: Is The Company Back?
Aug 26Medtronic: Still A Buy Before Earnings
Aug 17Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: MDT's dividends per share have been stable in the past 10 years.
Growing Dividend: MDT's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Medtronic Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (MDT) | 3.0% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.5% |
| Industry Average (Medical Equipment) | 1.7% |
| Analyst forecast (MDT) (up to 3 years) | 3.3% |
Notable Dividend: MDT's dividend (3.03%) is higher than the bottom 25% of dividend payers in the US market (1.44%).
High Dividend: MDT's dividend (3.03%) is low compared to the top 25% of dividend payers in the US market (4.49%).
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (77.3%), MDT's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (68.7%), MDT's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/26 20:14 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/07/25 |
| Annual Earnings | 2025/04/25 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medtronic plc is covered by 50 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kadambari Daptardar | Accountability Research Corporation |
| Harshit Gupta | Accountability Research Corporation |
| David Toung | Argus Research Company |